Janus Henderson Group PLC Sells 2,926 Shares of Molina Healthcare, Inc $MOH

Janus Henderson Group PLC lowered its position in Molina Healthcare, Inc (NYSE:MOH) by 11.3% during the first quarter, according to its most recent filing with the SEC. The firm owned 23,000 shares of the company’s stock after selling 2,926 shares during the period. Janus Henderson Group PLC’s holdings in Molina Healthcare were worth $3,065,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Baird Financial Group Inc. acquired a new position in Molina Healthcare in the first quarter valued at $210,000. NewEdge Advisors LLC grew its holdings in Molina Healthcare by 33.4% during the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after acquiring an additional 277 shares during the period. Jones Financial Companies Lllp raised its position in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after acquiring an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Molina Healthcare by 19.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after acquiring an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP acquired a new position in shares of Molina Healthcare in the 1st quarter valued at about $1,541,000. 98.50% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on MOH. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research report on Wednesday, April 29th. Barclays dropped their price target on Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating on the stock in a research note on Friday, July 24th. Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $129.00 price objective on shares of Molina Healthcare in a research report on Friday, April 24th. Finally, Morgan Stanley lifted their price objective on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $202.44.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.

Molina Healthcare Trading Up 2.5%

Shares of Molina Healthcare stock opened at $196.65 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $244.89. The stock has a 50 day moving average price of $209.25 and a two-hundred day moving average price of $177.81. The stock has a market capitalization of $10.27 billion, a PE ratio of -1,092.43, a price-to-earnings-growth ratio of 28.14 and a beta of 0.75.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. During the same period in the prior year, the firm earned $5.48 earnings per share. Molina Healthcare’s revenue for the quarter was down 4.8% on a year-over-year basis. As a group, equities analysts anticipate that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.